Abbott Laboratories (NYSE:ABT)
| 111.27 Delayed Data As of Jan 15 |  +1.23 / +1.12%Today’s Change | 61.61 Today|||52-Week Range 115.14 | +1.63% Year-to-Date |
ABT Regular Dividend: ABT began trading ex-dividend on 01/14/21. A $0.45 dividend will be paid to shareholders of record as of 01/15/21.
Latest ABT News | Press Releases
| Quidel: Looking Beyond the Recent Surge in the Share Price Jan 18 / GuruFocus News - Paid Partner Content | My Best Growth Stock for 2021 Jan 14 / MotleyFool.com - Paid Partner Content |
| What's in Store for UnitedHealth (UNH) This Earnings Season? Jan 18 / Zacks.com - Paid Partner Content | 2 Healthcare Stocks to Buy in 2021 and Hold for the Next Decade Jan 14 / MotleyFool.com - Paid Partner Content |
| What's in Store for Intuitive Surgical's (ISRG) Q4 Earnings? Jan 15 / Zacks.com - Paid Partner Content | My Top 3 Large-Cap Stocks to Own in 2021 Jan 14 / MotleyFool.com - Paid Partner Content |
| 5 Top Healthcare Stocks for 2021 Jan 15 / StockNews.com - Paid Partner Content | Testing Space in Focus Again Thanks to New Wave of Coronavirus Jan 13 / Zacks.com - Paid Partner Content |
| The Zacks Analyst Blog Highlights: Abbott Lab, QIAGEN, Quidel, Hologic and Quest Diagnostics Jan 14 / Zacks.com - Paid Partner Content | 3 Dividend Aristocrats to Buy Right Now Jan 13 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 110.04 |
| Today’s open | 110.22 |
| Day’s range | 109.42 - 111.61 |
| Volume | 4,480,173 |
| Average volume (3 months) | 4,847,581 |
| Market cap | $197.3B |
Data as of 4:19pm ET, 01/15/2021
Growth & Valuation
| Earnings growth (last year) | +54.92% |
| Earnings growth (this year) | +9.58% |
| Earnings growth (next 5 years) | +12.20% |
| Revenue growth (last year) | +4.34% |
| P/E ratio | 59.2 |
| Price/Sales | 4.85 |
| Price/Book | 6.31 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| BDXBecton Dickinson and... | +4.01 | +1.56% |
| BSXBoston Scientific Co... | +0.17 | +0.47% |
| BAXBaxter International... | 0.00 | 0.00% |
| DXCMDexCom Inc | +2.24 | +0.64% |
Data as of 4:00pm ET, 01/15/2021
Financials
| Next reporting date | January 27, 2021 |
| EPS forecast (this quarter) | $1.35 |
| Annual revenue (last year) | $31.9B |
| Annual profit (last year) | $3.7B |
| Net profit margin | 11.49% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Abbott Park, Illinois |
Forecasts
